Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin
Sponsor and Collaborators
M.D. Anderson Cancer Center
OSI Pharmaceuticals
Contact
Bonnie S. Glisson, MD, BS 713-792-6363
Investigator
Bonnie S. Glisson, MD, BS UT MD Anderson Cancer Center
ClinicalTrials.gov Identifier
NCT01059305
Please login or register first to view this content.
You’ve read {{metering-count}} of {{metering-total}} articles this month.
We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.
{{login-button}} {{register-button}}
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
{{login-button}} {{register-button}}
Please login or register first to view this content.